tradingkey.logotradingkey.logo
Discount
Tradingkey

Mckesson Corp

MCK
Add to Watchlist
1069.430USD
+7.270+0.68%
Close 11-20 16:00(ET)
124.68BMarket Cap
27.77P/E TTM
After-hours 19:00 (ET)1069.430USD+1.540+0.14%

Today

+0.68%

5 Days

-3.03%

1 Month

+3.82%

6 Months

+42.01%

Year to Date

+30.76%

1 Year

+26.39%

Key Figures

1076.720Open
1087.980High
129.72KVolume
27.77P/E TTM
23.38P/E Dynamic
3.170Dividend TTM
0.11%Turnover Ratio
1062.160Prev. Close
1042.860Low
139.75MTurnover
37.85P/E Static
-31.54P/B
0.30%Div Yield TTM
6.48%ROA
1121.50052wk High
73.45Volume Ratio
3.29BNet Profit
116.59MShares
38.5275EPS TTM
0.33Beta
--ROE
722.11352wk Low
4.25%Amplitude
3.51%Gross Margin
124.68BMarket Cap
2.79Reward/Risk
2.01%Risk Rate
Recent
Transcripts
Mckesson Corp Stock (MCK) Moved Up by 4.52% on Oct 1: What Investors Need To Know

• McKesson extended its pharmaceutical distribution contract with CVS Health through June 2032. • Management reaffirmed its fiscal 2027 adjusted earnings outlook and long-term growth targets. • The company reported annual revenue of $403.43B and net profit of $4.76B.

TradingKeyThu, Oct 1
Mckesson Corp Stock (MCK) Moved Up by 3.13% on Sep 1: Key Drivers Unveiled

• McKesson agreed to acquire Precision Medicine Group to expand its oncology portfolio. • The company raised its quarterly dividend payout by fifteen percent. • Annual revenue reached $403.43 billion, ranking first in the industry.

TradingKeyTue, Sep 1
Mckesson Corp Stock (MCK) Moved Up by 3.25% on Aug 25: What Signal Does It Send?

• McKesson agreed to acquire Precision Medicine Group for $2.25 billion. • Q1 revenue and earnings exceeded estimates, prompting higher full-year guidance. • Annual revenue reached $403.43B, ranking first in the pharmaceutical industry.

TradingKeyTue, Aug 25
Mckesson Corp Stock (MCK) Moved Up by 3.13% on Aug 21: A Full Analysis

• McKesson exceeded Wall Street estimates and raised full-year earnings guidance. • Strong cash flow drove share repurchases and a dividend increase. • Analysts issued Buy ratings with an average price target of $979.83.

TradingKeyFri, Aug 21
Mckesson Corp Stock (MCK) Moved Down by 3.44% on Aug 6: What Signal Does It Send?

• McKesson shares declined following margin contraction in the U.S. Pharmaceutical segment. • Management maintained full-year earnings guidance, disappointing investors seeking an upward revision. • Regulatory scrutiny regarding drug pricing and reimbursement creates significant uncertainty for the firm.

TradingKeyThu, Aug 6
Mckesson Corp Stock (MCK) Closed Up by 5.08% on Aug 5: What Investors Need To Know

• McKesson reported fiscal first-quarter earnings exceeding consensus expectations across core metrics. • Management raised full-year earnings guidance, citing strength in oncology and biopharma services. • The company leads its industry with $403.43 billion in latest annual revenue.

TradingKeyWed, Aug 5

Mckesson Corp's Score

0.01vs previous score
Forecast8.21
Financial Health9.02
Technical3.79
Valuation Dimensions9.76
Institutional Confidence10.00
Risk Assessment8.81

Media Coverage

Coverage Level

34°C

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
1031.400Target Price
+3.70%Upside Space
Current Rating2026-112026-102026-092026-082026-072026-062026-052026-04
Strong Buy66888766
Buy99999101010
Hold44222222
Sell00000000
Strong Sell00000000

Mckesson Corp Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Sell
Summary
Neutral
Moving Average
Buy

Mckesson Corp Latest Earnings Call Transcripts

McKesson (MCK) Fiscal Q2 2027 Earnings Call: EPS Guidance Raised

McKesson fiscal Q2 2027 revenue rose 8% to $111 billion, adjusted EPS reached $11.68, and management raised full-year guidance to $45.60-$46.40.

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2027Q2
Earnings / Forecast
10.47/10.70
Revenue / Forecast
110.96B/109.88B

Mckesson Corp Profile

SectorPharmaceuticals
Ticker SymbolMCK
Number of employees43000
CountryUnited States of America

Ownership

ShareholdersProportion
Vanguard Capital Management, LLC6.62%
BlackRock Institutional Trust Company, N.A.5.74%
State Street Investment Management (US)4.81%
MFS Investment Management2.81%
Shareholder TypesProportion
Investment Advisor48.66%
Investment Advisor/Hedge Fund32.95%
Pension Fund3.22%
Research Firm2.88%

FAQs

What is the current price of Mckesson Corp (MCK)?

The current price of Mckesson Corp (MCK) is 1069.72.

What is the symbol of Mckesson Corp?

The ticker symbol of Mckesson Corp is MCK.

What is the 52-week high of Mckesson Corp?

The 52-week high of Mckesson Corp is 1121.50.

What is the 52-week low of Mckesson Corp?

The 52-week low of Mckesson Corp is 722.11.

What is the market capitalization of Mckesson Corp?

The market capitalization of Mckesson Corp is 124.72B.

Is Mckesson Corp (MCK) currently rated as Buy, Hold, or Sell?

According to analysts, Mckesson Corp (MCK) has an overall rating of Buy, with a price target of 1031.40.

What is the Earnings Per Share (EPS TTM) of Mckesson Corp (MCK)?

The Earnings Per Share (EPS TTM) of Mckesson Corp (MCK) is 38.53.
tradingkey.logotradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.